Please enable JS

Frontier Pharma: Alzheimer’s Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression

Frontier Pharma: Alzheimer’s Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression

Publication ID: 
GBI0517006
Publication Date: 
May 01, 2017
Pages: 
101
Publisher: 
GBI Research
Region: 
$6,995.00
Please choose the suitable license type from above. More details are at given under tab "Report License Types" below.
Custom Market Research Reports
Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.